Edusa Pharmaceuticals, Inc.
Records under this name other than patents Edusa Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Edusa Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,846,823 | Method of treating lower urinary tract disorders Lapsed on the fee record Ended Jan 25, 2013 · USPTO record | Lapsed on the fee record | Ended Jan 25, 2013 | USPTO record |
| US 7,470,690 | 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder Lapsed on the fee record Ended Dec 30, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 30, 2012 | USPTO record |
| US 7,459,430 | Methods of using ziconotide to treat overactive bladder Lapsed on the fee record Ended Dec 2, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 2, 2012 | USPTO record |
| US 7,223,754 | Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders Lapsed on the fee record Ended May 29, 2011 · USPTO record | Lapsed on the fee record | Ended May 29, 2011 | USPTO record |
| US 7,220,748 | Use of 4-(2-Flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D)-pyrimidine for treating of urinary incontinence Lapsed on the fee record Ended May 22, 2011 · USPTO record | Lapsed on the fee record | Ended May 22, 2011 | USPTO record |
| US 7,125,848 | Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators Lapsed on the fee record Ended Oct 24, 2010 · USPTO record | Lapsed on the fee record | Ended Oct 24, 2010 | USPTO record |
| US 7,115,606 | Method of treating lower urinary tract disorders Lapsed on the fee record Ended Oct 3, 2010 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2010 | USPTO record |
| US 7,094,786 | Method of treating nausea, vomiting, retching or any combination thereof Lapsed on the fee record Ended Aug 22, 2010 · USPTO record | Lapsed on the fee record | Ended Aug 22, 2010 | USPTO record |
| US 7,084,116 | Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators Lapsed on the fee record Ended Aug 1, 2010 · USPTO record | Lapsed on the fee record | Ended Aug 1, 2010 | USPTO record |
| US 7,041,704 | Methods of treating gastrointestinal tract disorders using sodium channel modulators Lapsed on the fee record Ended May 9, 2010 · USPTO record | Lapsed on the fee record | Ended May 9, 2010 | USPTO record |